ATE469674T1 - 5-aminolävulinsäure-derivate zur behandlung von akne - Google Patents

5-aminolävulinsäure-derivate zur behandlung von akne

Info

Publication number
ATE469674T1
ATE469674T1 AT05800149T AT05800149T ATE469674T1 AT E469674 T1 ATE469674 T1 AT E469674T1 AT 05800149 T AT05800149 T AT 05800149T AT 05800149 T AT05800149 T AT 05800149T AT E469674 T1 ATE469674 T1 AT E469674T1
Authority
AT
Austria
Prior art keywords
acne
treatment
acid derivatives
aminolevulic acid
aminolevulic
Prior art date
Application number
AT05800149T
Other languages
English (en)
Inventor
Aslak Godal
Jo Klaveness
Hilde Morris
Original Assignee
Photocure Asa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Photocure Asa filed Critical Photocure Asa
Application granted granted Critical
Publication of ATE469674T1 publication Critical patent/ATE469674T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/0613—Apparatus adapted for a specific treatment
    • A61N5/0616—Skin treatment other than tanning
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0061—5-aminolevulinic acid-based PDT: 5-ALA-PDT involving porphyrins or precursors of protoporphyrins generated in vivo from 5-ALA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Radiology & Medical Imaging (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Semiconductor Lasers (AREA)
AT05800149T 2004-11-10 2005-11-04 5-aminolävulinsäure-derivate zur behandlung von akne ATE469674T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0424833A GB0424833D0 (en) 2004-11-10 2004-11-10 Method
PCT/GB2005/004253 WO2006051269A1 (en) 2004-11-10 2005-11-04 Treatment of acne using derivatives of 5-aminolevulinic acid

Publications (1)

Publication Number Publication Date
ATE469674T1 true ATE469674T1 (de) 2010-06-15

Family

ID=33523497

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05800149T ATE469674T1 (de) 2004-11-10 2005-11-04 5-aminolävulinsäure-derivate zur behandlung von akne

Country Status (16)

Country Link
US (2) US20080188558A1 (de)
EP (1) EP1814534B1 (de)
JP (1) JP5134370B2 (de)
CN (1) CN101056626B (de)
AT (1) ATE469674T1 (de)
AU (1) AU2005303565B2 (de)
CA (1) CA2586195C (de)
DE (1) DE602005021677D1 (de)
DK (1) DK1814534T3 (de)
ES (1) ES2344986T3 (de)
GB (1) GB0424833D0 (de)
PL (1) PL1814534T3 (de)
PT (1) PT1814534E (de)
RU (1) RU2385718C2 (de)
SI (1) SI1814534T1 (de)
WO (1) WO2006051269A1 (de)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0525504D0 (en) 2005-12-14 2006-01-25 Bristol Myers Squibb Co Antimicrobial composition
US20110224598A1 (en) * 2010-03-12 2011-09-15 Daniel Barolet Radiant near infrared light emitting diode exposure as skin preparation
GB0609809D0 (en) * 2006-05-17 2006-06-28 Photocure Asa Product
KR100796450B1 (ko) * 2006-06-29 2008-01-22 전남대학교산학협력단 5-아미노레불린산의 불포화 알킬 에스터 및 약학적으로허용되는 그의 염, 이의 제조방법 및 이의 용도
GB0700580D0 (en) * 2007-01-11 2007-02-21 Photocure Asa Use
WO2009003173A1 (en) 2007-06-27 2008-12-31 The General Hospital Corporation Method and apparatus for optical inhibition of photodymanic therapy
CA2709274A1 (en) 2007-12-14 2009-06-25 Photoderma Sa Novel compounds useful in therapeutic and cosmetic methods
GB0823265D0 (en) * 2008-12-20 2009-01-28 Convatec Technologies Inc Antimicrobial Composition
GB0823472D0 (en) 2008-12-23 2009-01-28 Photocure Asa Product
GB0900461D0 (en) 2009-01-12 2009-02-11 Photocure Asa Photodynamic therapy device
CA2763923C (en) 2009-06-11 2016-09-13 Photocure Asa Semi-solid compositions comprising 5-ala esters
WO2011107478A1 (en) 2010-03-01 2011-09-09 Photocure Asa Cosmetic compositions
EP2585111A1 (de) 2010-06-23 2013-05-01 Photocure ASA Hyperosmotische zubereitungen mit 5-amino-lävulinsäure oder derivaten als fotosensibilisatoren
ES2620780T3 (es) 2010-07-09 2017-06-29 Photocure Asa Dispositivos que contienen composiciones secas para su uso en terapia fotodinámica
JP5945540B2 (ja) 2010-08-27 2016-07-05 シエナ バイオファーマシューティカルズ，インク． 標的とされた熱変調のための組成物及び方法
US9572880B2 (en) 2010-08-27 2017-02-21 Sienna Biopharmaceuticals, Inc. Ultrasound delivery of nanoparticles
GB201020236D0 (en) 2010-11-30 2011-01-12 Convatec Technologies Inc A composition for detecting biofilms on viable tissues
EP2657346B1 (de) 2010-12-24 2017-08-23 ARKRAY, Inc. Verfahren für den nachweis von krebszellen
KR101308652B1 (ko) * 2011-05-19 2013-09-13 제너럴바이오(주) Ｍａｌ을 이용한 여드름 치료 조성물
EP2766049A1 (de) 2011-10-14 2014-08-20 Photocure ASA Photodynamische diagnose von abweichungen des epithels der speiseröhre mit einem 5-ala ester
WO2013053904A1 (en) 2011-10-14 2013-04-18 Photocure Asa Stent
RU2615870C2 (ru) 2011-12-19 2017-04-11 ФотоКьюэр АСА Устройство облучения
WO2013092936A2 (en) * 2011-12-20 2013-06-27 Galderma Research & Development Use of 5-aminolevulinic acid and esters, in combination with a vitamin d derivative or analog in photochemotherapy, and their uses in treating acne
MX364940B (es) * 2012-08-03 2019-05-15 Photocure Asa Compuestos.
US9387341B2 (en) 2012-08-10 2016-07-12 Dusa Pharmaceuticals, Inc. Method for the treatment of acne
US20140067024A1 (en) 2012-08-30 2014-03-06 Photocure Asa Dual panel photodynamic therapy lamp
DK2906286T3 (en) 2012-10-11 2017-07-17 Nanocomposix Inc SILVER CHARACTER COMPOSITIONS AND PROCEDURES
MX2015007771A (es) 2012-12-20 2015-09-04 Convatec Technologies Inc Procesamiento de fibras celulosicas quimicamente modificadas.
KR101623553B1 (ko) * 2013-07-23 2016-05-23 동성제약주식회사 여드름 치료, 예방 또는 개선에 유효한 클로린 e6
US10716855B2 (en) * 2013-12-20 2020-07-21 Galderma Research & Development Pulse photodynamic treatment of photodamaged skin
MX2016009054A (es) * 2014-01-10 2017-01-18 Sebacia Inc Intervalos de tratamiento para el uso de composiciones que comprenden materiales absorbentes de energia para aplicaciones dermatologicas.
US9956426B2 (en) 2015-02-26 2018-05-01 Amol Punjabi Upconverting nanoparticles
US20160287615A1 (en) * 2015-04-03 2016-10-06 BioPharmX, Inc. Novel encapsulation of fluorescent, photo-sensitive, or oxygen-sensitive active ingredient for topical application
US10603508B2 (en) 2015-10-15 2020-03-31 Dusa Pharmaceuticals, Inc. Adjustable illuminators and methods for photodynamic therapy and diagnosis
PL3362145T3 (pl) 2015-10-15 2021-07-19 Dusa Pharmaceuticals, Inc. Regulowany oświetlacz do terapii fotodynamicznej i diagnostyki
CN106801037B (zh) * 2017-01-06 2021-01-19 中国人民解放军***福州总医院 体外痤疮炎症模型的建立方法及其应用
US10632324B2 (en) 2017-04-27 2020-04-28 9127-4910 Quebec Inc. Method for the treatment of skin tissues
US20200261580A1 (en) * 2017-07-17 2020-08-20 Andrea Willey Photodynamic Therapy Method for Skin Disorders
US10357567B1 (en) 2018-01-12 2019-07-23 Dusa Pharmaceuticals, Inc. Methods for photodynamic therapy
KR102171200B1 (ko) * 2018-11-20 2020-10-28 제너럴바이오(주) 5-아미노레불린산 수화염화물과 그 유도체를 유효성분으로 함유하는 여드름성 피부염 개선 또는 그의 조성물
KR102265592B1 (ko) * 2020-10-29 2021-06-17 김진왕 5-아미노레불린산 수화염화물을 포함하는 조성물

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5234940A (en) 1989-07-28 1993-08-10 Queen's University Photochemotherapeutic method using 5-aminolevulinic acid and precursors thereof
US5079262A (en) * 1989-07-28 1992-01-07 Queen's University At Kingston Method of detection and treatment of malignant and non-malignant lesions utilizing 5-aminolevulinic acid
US5422093A (en) * 1989-07-28 1995-06-06 Queen's University Photochemotherapeutic method using 5-aminolevulinic acid and precursors thereof
US6710066B2 (en) * 1989-07-28 2004-03-23 Queen's University At Kingston Photochemotherapeutic method using 5-aminolevulinic acid and other precursors of endogenous porphyrins
US5955490A (en) * 1989-07-28 1999-09-21 Queen's University At Kingston Photochemotherapeutic method using 5-aminolevulinic acid and other precursors of endogenous porphyrins
US5713845A (en) * 1991-10-29 1998-02-03 Thermolase Corporation Laser assisted drug delivery
ES2160600T3 (es) 1992-09-21 2001-11-16 Quadra Logic Tech Inc Activacion transcutanea in vivo de agentes fotosensibles en la sangre.
ES2157424T3 (es) * 1995-03-10 2001-08-16 Photocure Asa Esteres de acido 5-aminolevulinico como agentes fotosensibilizantes en fotoquimioterapia.
GB9700396D0 (en) * 1997-01-10 1997-02-26 Photocure As Photochemotherapeutic compositions
JPH1112197A (ja) 1997-06-18 1999-01-19 Cosmo Sogo Kenkyusho:Kk 悪性腫瘍診断剤及び治療剤
US6183773B1 (en) * 1999-01-04 2001-02-06 The General Hospital Corporation Targeting of sebaceous follicles as a treatment of sebaceous gland disorders
DE10003620A1 (de) * 2000-01-28 2001-08-02 Asat Ag Applied Science & Tech 5-Aminolävulinsäure-Formulierung in nichtwässrigen Lösungsmitteln
GB0018528D0 (en) * 2000-07-27 2000-09-13 Photocure Asa Compounds
ATE463237T1 (de) * 2000-08-16 2010-04-15 Gen Hospital Corp Topische aminolevulinsäure-photodynamische therapie für akne vulgaris
GB0118251D0 (en) * 2001-07-26 2001-09-19 Photocure Asa Method
ATE386544T1 (de) * 2001-11-09 2008-03-15 Quadra Logic Tech Inc Photodynamische therapie zur behandlung von haarausfall
US20040048842A1 (en) * 2002-09-10 2004-03-11 Mcmillan Kathleen Method of treating skin disorders
US20050209330A1 (en) * 2004-03-22 2005-09-22 Syneron Medical Ltd. Method of treatment of skin
US20050209331A1 (en) * 2004-03-22 2005-09-22 Syneron Medical Ltd. Method of treatment of skin
GB0406917D0 (en) 2004-03-26 2004-04-28 Photocure Asa Compounds

Also Published As

Publication number Publication date
WO2006051269A1 (en) 2006-05-18
DK1814534T3 (da) 2010-09-20
US20130066256A1 (en) 2013-03-14
GB0424833D0 (en) 2004-12-15
RU2007115601A (ru) 2008-12-20
AU2005303565B2 (en) 2011-04-14
CN101056626A (zh) 2007-10-17
US8546447B2 (en) 2013-10-01
RU2385718C2 (ru) 2010-04-10
ES2344986T3 (es) 2010-09-13
CA2586195A1 (en) 2006-05-18
SI1814534T1 (sl) 2010-09-30
PT1814534E (pt) 2010-06-15
PL1814534T3 (pl) 2010-11-30
CA2586195C (en) 2013-12-31
US20080188558A1 (en) 2008-08-07
EP1814534A1 (de) 2007-08-08
EP1814534B1 (de) 2010-06-02
CN101056626B (zh) 2011-12-14
JP5134370B2 (ja) 2013-01-30
AU2005303565A1 (en) 2006-05-18
DE602005021677D1 (de) 2010-07-15
JP2008519812A (ja) 2008-06-12

Similar Documents

Publication Publication Date Title
ATE469674T1 (de) 5-aminolävulinsäure-derivate zur behandlung von akne
CY1108514T1 (el) Παραγωγα 1-φαινυλαλκανεκαρβοξυλικου οξεος για τη θεραπεια νευρογενων ασθενειων
ATE390407T1 (de) Phenethanolamin-derivate zur behandlung von atemwegserkrankungen
DE50311898D1 (de) Fredericamycin-derivate als arzneimittel zur tumorbehandlung
CY1110835T1 (el) Διφαινυλ παραγωγα και η χρηση τους στη θεραπεια της ηπατιτιδας c
ATE476414T1 (de) Biphenyloxyessigsäurederivate zur behandlung von atemwegserkrankungen
ATE554084T1 (de) N-hydroxyacrylamidverbindungen
CY1116831T1 (el) ΧΡΗΣΗ 24-norUDCA
DE60312736D1 (de) 1,2,4-triaminobenzolderivate zur behandlung von erkrankungen des zentralnervensystems
MX2012008509A (es) Agente terapeutico o profilactic para enfermedades del tracto biliar.
ATE399758T1 (de) Derivate von 1-phenylalkancarbonsäuren zur behandlung von neurodegenerativen krankheiten
DE602004006118D1 (de) 2,3,4,5-TETRAHYDROBENZOiFöi1,4öOXAZEPIN-5-CARBONSÄUREAMID DERIVATE ALS GAMMA-SECRETASE INHIBITOREN ZUR BEHANDLUNG VON ALZHEIMER
WO2006133231A3 (en) Treatment for neurodegenerative diseases
EA200600115A1 (ru) Производные 2-аминобензойной кислоты
BRPI0509881A (pt) combinação terapêutica para tratamento da doença de alzheimer
CY1106385T1 (el) Χρηση παραγωγων της εποθειλονης για τη θepαπεια του υπepπαραθυρεοειδισμου
ATE464042T1 (de) Verwendung von neboglamine zur behandlung von schizophrenie
ATE442848T1 (de) Isoxazolsäure-derivat zur linderung neuropathischer schmerzen
WO2008149971A1 (ja) 脳動脈瘤の治療または予防薬
ATE520666T1 (de) Derivate von 18-amino-substituierten analoga des geldamycin-hydrochinons mit cyctotoxischer wirkung für die behandlung von krebs
TH100046A (de)
TH103568A (th) อนุพันธ์ของ 6-ไพริมิดินิล-ไพริมิด-2-โอนชนิดใหม่
TH100046B (th) วิธีการของการบำบัดหรือการป้องกันการลดการเสื่อม, การบาดเจ็บ หรือ ความเสียหายของเนื้อเยื่อเนื่องมาจากโรคของเยื่อเมือก
WO2010062144A3 (ko) 에타크리닉 산을 포함하는 트란스글루타미나제 관련 질환 예방 또는 치료용 조성물 및 그를 이용하는 트란스글루타미나제 관련 질환 예방 또는 치료 방법

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1814534

Country of ref document: EP